Yacine Maringer - Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 43 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Efficacy of the Peptide-Based COVID-19 T Cell Activator CoVac-1 in Healthy Adults

Claudia Tandler,Jonas S. Heitmann, Tanja M. Michel,Maddalena Marconato,Simon U. Jaeger,Christian M. Tegeler,Monika Denk,Marion Richter, Melek Tutku Oezbek,Yacine Maringer,Sarah M. Schroeder,Nicole Schneiderhan-Marra,Karl-Heinz Wiesmueller,Michael Bitzer,Natalia Ruetalo,Michael Schindler,Christoph Meisner,Imma Fischer,Hans-Georg Rammensee,Helmut R. Salih,Juliane S. Walz

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2024): 69-77

Cited0Views0WOSBibtex

813MO Phase I Trial of a Personalized Multi-Peptide Vaccine Combined with the TLR1/2 Ligand XS15 under Bruton-Tyrosine-Kinase Inhibitor (btki) Treatment in Chronic Lymphocytic Leukemia (CLL) Patients

C. Hackenbruch,J.S. Heitmann, S. Jung,Y. Maringer, M. Wacker,A. Nelde,M. Marconato, L. Zieschang, C. Kammer, M.T. Özbek, M. Richter,M. Denk, H.R. Salih,J.S. Walz

Annals of Oncology (2024)

Cited0Views0Bibtex

FusionVAC22_01: A Phase I Clinical Trial Evaluating a DNAJB1-PRKACA Fusion Transcript-Based Peptide Vaccine Combined with Immune Checkpoint Inhibition for Fibrolamellar Hepatocellular Carcinoma and Other Tumor Entities Carrying the Oncogenic Driver Fusion

Michael Bitzer,Christopher Hackenbruch,Jens Bauer,Jonas S. Heitmann,Yacine Maringer,Annika Nelde,Helmut R. Salih,Juliane S. Walz

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): TPS580-TPS580

Cited0Views0WOSBibtex

Ivac-Xs15-cll01: Personalized Multi-Peptide Vaccination in Combination with the TLR1/2 Ligand XS15 in CLL Patients Undergoing BTK-inhibitor-based Regimens

Alexander Englisch, Clara Hayn, Susanne Jung,Jonas S. Heitmann,Christopher Hackenbruch,Yacine Maringer,Annika Nelde,Marcel Wacker,Monika Denk, Lisa Zieschang, Christine Kammer, Peter Martus,Helmut R. Salih,Juliane S. Walz

FRONTIERS IN ONCOLOGY (2024)

Cited0Views0WOSBibtex

Validation of HLA Presented Tumor-Exclusive Peptides in an Independent Cohort of Head and Neck Squamous Cell Carcinoma

Simon Laban,Sarah Schroeder, Lena Muehlenbruch, Adrian von Witzleben, Tsima Abou Kors, Cornelia Brunner,Yacine Maringer,Annika Nelde, Naomi Hoenisch Gravel,Jonas Scheid,Marissa L. Dubbelaar, Thorben Gross, Johann M. Kraus,Hans A. Kestler, Paul-Stefan Mauz, Hubert Loewenheim,Jens Greve,Thomas K. Hoffmann, Hans-Georg Rammensee,Juliane S. Walz

Journal of Clinical Oncologyno. 16_suppl (2024): 6047-6047

Cited0Views0Bibtex

AML-VAC-XS15-01: Protocol of a First-in-human Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Multi-Peptide Vaccine Based on Leukemia Stem Cell Antigens in Acute Myeloid Leukemia Patients

Susanne Jung,Annika Nelde,Yacine Maringer,Monika Denk, Lisa Zieschang, Christine Kammer, Melek Özbek, Peter Martus, Christopher Hackenbruch, Alexander Englisch,Jonas S Heitmann,Helmut R Salih,Juliane S Walz

Frontiers in oncology (2024): 1458449-1458449

Cited0Views0WOSBibtex

A Phase I trial of personalized multi-peptide vaccines combined with the TLR1/2 ligand XS15 under Bruton-Tyrosine-Kinase inhibitor (BTKi) treatment in CLL patients

J. S. Heitmann,Y. Maringer,M. Wacker,M. Marconato,A. Nelde, C. Hackenbruch, A. Seller, S. M. Greiner,B. Federmann, M. Richter,M. Denk,H. R. Salih,J. S. Walz

ONCOLOGY RESEARCH AND TREATMENT（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn